Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/INCANNEX-HEALTHCARE-INC-133985168/news/Incannex-Healthcare-Inc-Update-on-Ihl-42X-Drug-Candidate-in-Phase-2-3-Clinical-Trial-in-Obstructive-45513367/?utm_source=whatsapp&utm_medium=social&utm_campaign=share